Oncology Views & Analysis

Views & Analysis

Making it as an oncology biotech in the united kingdom

Making it as an oncology biotech in the UK

We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem

Views & Analysis

Helping HCPs navigate the ever-evolving advanced cancer land...

OPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can help ensure maximum patient benefit

Views & Analysis

Adapting for the future of oncology

External pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace.

Views & Analysis

ASCO 2020: Scientific advances & what’s impacting doctors an...

Despite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Richard Staines that the 2020 American Society of Clini

Views & Analysis

Deep Dive: The Future of Oncology

This year’s ASCO showed us that while COVID-19 might be front and centre of everyone’s minds, the desire to see real change in cancer treatment hasn’t diminished. In this issue

Views & Analysis

COVID-19 and cancer: can pharma stymie the pandemic’s impact...

The COVID-19 pandemic may lead to increased cases of cancer mortality – what can biopharma companies do to help lessen the impact?

Making it as an oncology biotech in the UK

Helping HCPs navigate the ever-evolving advanced cancer land...

Adapting for the future of oncology

ASCO 2020: Scientific advances & what’s impacting doctors an...

Deep Dive: The Future of Oncology

COVID-19 and cancer: can pharma stymie the pandemic’s impact...

On AI and computational support of biochemistry, with Alan R...

The AI imperative: Establishing the standard for modern clin...

Views & Analysis

Editor's Picks